Malesker M A, Soori G S, Malone P M, Mahowald J A, Housel G J
Immanuel Medical Center, Omaha, NE, USA.
Ann Pharmacother. 1995 Sep;29(9):867-9. doi: 10.1177/106002809502900907.
To describe the first incidence of eosinophilia following administration of bupropion.
The patient was a 72-year-old woman admitted for evaluation of chest pain. During hospitalization, the eosinophil count reached 0.60 fraction of 1.00, with absolute eosinophil count of 6693 x 10(6)/L and a white blood cell count of 18.5 x 10(9)/L. She had been receiving bupropion therapy for 5 days prior to this admission.
Potential causes of the eosinophilia, including disease states and medications, were reviewed comprehensively and ruled out. A review of the literature (MEDLINE 1966-1994) did not identify previous cases of eosinophilia associated with bupropion therapy. Causes of eosinophilia include parasitic infections, allergic diseases, and medication use. A proposed mechanism for the occurrence of eosinophilia in this patient is unknown.
Considering the temporal sequence of events, drugs administered prior to the development of eosinophilia, and the rapid decline of the eosinophil count following discontinuation of the medication, bupropion appears to be the precipitating agent.
描述安非他酮给药后首次出现嗜酸性粒细胞增多症的情况。
患者为一名72岁女性,因胸痛入院评估。住院期间,嗜酸性粒细胞计数达到1.00中的0.60,绝对嗜酸性粒细胞计数为6693×10⁶/L,白细胞计数为18.5×10⁹/L。此次入院前她已接受安非他酮治疗5天。
全面回顾了嗜酸性粒细胞增多症的潜在病因,包括疾病状态和药物,并予以排除。对文献(MEDLINE 1966 - 1994)的检索未发现先前有与安非他酮治疗相关的嗜酸性粒细胞增多症病例。嗜酸性粒细胞增多症的病因包括寄生虫感染、过敏性疾病和药物使用。该患者发生嗜酸性粒细胞增多症的推测机制尚不清楚。
考虑到事件的时间顺序、嗜酸性粒细胞增多症出现之前使用的药物以及停药后嗜酸性粒细胞计数的迅速下降,安非他酮似乎是诱发因素。